Company Overview
Snapshot
Founded in June 2015 by Omer Zelka, ElastiMed operates with 1–10 employees. The company has raised a total of $4.2 million across six funding rounds from six investors.
Business overview
ElastiMed develops a wearable medical device designed to enhance blood circulation in the legs, addressing venous and lymphatic diseases. Its proprietary technology utilizes smart materials to create a battery-operated device that continuously massages the legs. This solution aims to provide a comfortable, effective, and user-friendly treatment for swelling, ulcers, and blood clot prevention. The device is also applicable for athletes seeking faster recovery and integrates IoT sensors for data generation and compliance monitoring. ElastiMed operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics, serving patients, healthcare providers, and athletes.
Strategic signal
In January 2025, ElastiMed appointed Dr. Steve Elias to its Medical Advisory Board, signaling a strategic move to strengthen its clinical expertise and market credibility. This appointment suggests a focus on enhancing product development and clinical validation for its wearable medical devices, which could accelerate market adoption and investor confidence in the company's long-term growth trajectory.
Log in to access full profile ›Company Intelligence Q&A
- What is ElastiMed's primary focus?
- ElastiMed specializes in developing wearable medical devices to improve blood circulation in the legs, addressing venous and lymphatic diseases through continuous massage technology.
- When was ElastiMed founded?
- ElastiMed was founded in June 2015 by Omer Zelka.
- What was a key recent development for ElastiMed?
- In January 2025, ElastiMed appointed Dr. Steve Elias to its Medical Advisory Board, aiming to enhance its medical expertise and strategic direction.